During the past decade, Yale Dermatology Associates conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Yale Dermatology Associates" are "Dermatitis" (1 trials), "Dermatitis, Atopic" (1 trials), "Eczema" (1 trials), "Genetic Disease, Inborn" (1 trials) and "Hemangioma" (1 trials). Many other conditions were trialed in "Yale Dermatology Associates" in a lesser frequency.

Most popular intervention types in "Yale Dermatology Associates" are "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Care provided by general pediatrician" (1 trials) and "Care provided by pediatric dermatologist" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yale Dermatology Associates" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Yale Dermatology Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Yale Dermatology Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yale Dermatology Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".